Qrons Inc. Share · US74737F1012 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Qrons Inc.
No Price
Company Profile for Qrons Inc. Share
Qrons Inc., a biotechnology company, engages in development of biotech products, treatments, and technologies to combat neuronal diseases. Its product candidates include QS100, an injury specific, 3D printable, implantable mesenchymal stem cells (MSCs)-synthetic hydrogel to treat penetrating brain injuries; and QS200, an injectable MSCs-synthetic hydrogel for the treatment of concussions and other diffused axonal injuries. The company was formerly known as BioLabMart Inc. and changed its name to Qrons Inc. in August 2017. Qrons Inc. was incorporated in 2016 and is based in Long Island City, New York.
Company Data
Name Qrons Inc.
Company Qrons Inc.
Website
https://qrons.com
Primary Exchange 
UTC
UTC
ISIN US74737F1012
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Cory J. Rosenberg
Country United States of America
Currency USD
Employees 0,0 T
Address 28-10 Jackson Avenue, 11101 Long Island City
IPO Date 2017-09-12
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | QRON |
More Shares
Investors who hold Qrons Inc. also have the following shares in their portfolio:
